Carisoprodol withdrawal syndrome resembling neuroleptic malignant syndrome: Diagnostic dilemma

Carisoprodol withdrawal syndrome resembling neuroleptic malignant syndrome: Diagnostic dilemma

Soma (Carisoprodol) is N-isopropyl-2 methyl-2-propyl-1,3-propanediol dicarbamate; a commonly prescribed, centrally acting skeletal muscle relaxant. Neuroleptic malignant syndrome (NMS) is a potentially life-threatening adverse effect of antipsychotic agents. Although diagnostic criteria for NMS have...

Full description

Bibliographic Details
Main Authors: Gunchan Paul, Gautam L Parshotam, Rajneesh Garg
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Journal of Anaesthesiology Clinical Pharmacology
Subjects:
Carisoprodol
carisoprodol abuse
carisoprodol withdrawal
neuroleptic malignant syndrome
soma
Online Access:http://www.joacp.org/article.asp?issn=0970-9185;year=2016;volume=32;issue=3;spage=387;epage=388;aulast=Paul

Internet

http://www.joacp.org/article.asp?issn=0970-9185;year=2016;volume=32;issue=3;spage=387;epage=388;aulast=Paul

Similar Items